95 related articles for article (PubMed ID: 1904106)
1. [Combination antibacterial effects between aztreonam and eight other antibiotics].
Nishino T; Obana Y; Kuzui H; Murakami T
Jpn J Antibiot; 1991 Jan; 44(1):1-8. PubMed ID: 1904106
[TBL] [Abstract][Full Text] [Related]
2. [Bacterial combination effect between carumonam and eight other antibiotics].
Obana Y; Murakami T; Kuzui H; Nishino T
Jpn J Antibiot; 1990 Dec; 43(12):2094-101. PubMed ID: 2128341
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of clinical isolates to aztreonam].
Nagasawa Z; Nishimura T; Nagumo F; Ueda H; Tadano J; Katoh O; Yamada H
Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
[TBL] [Abstract][Full Text] [Related]
4. [An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Kumagai K; Otsuki H; Nishibuchi M; Takeda Y
Jpn J Antibiot; 1990 Sep; 43(9):1579-87. PubMed ID: 2124634
[TBL] [Abstract][Full Text] [Related]
5. [Combined effects of micronomicin and latamoxefi in vitro synergistic activities].
Kurimoto T; Okachi R
Jpn J Antibiot; 1983 Jul; 36(7):1599-603. PubMed ID: 6418932
[TBL] [Abstract][Full Text] [Related]
6. [Antibacterial activity of aztreonam against clinical isolates].
Igari J
Jpn J Antibiot; 1994 May; 47(5):502-20. PubMed ID: 8051793
[TBL] [Abstract][Full Text] [Related]
7. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Saito M; Azuma K; Nishino T; Tanino T
Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility of clinical isolates to aztreonam].
Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K
Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of clinical bacterial isolates to aztreonam].
Murase M; Niiya T; Takeuchi N
Jpn J Antibiot; 1987 Sep; 40(9):1698-706. PubMed ID: 3121888
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibility of clinically isolated strains to aztreonam].
Daimon Y
Jpn J Antibiot; 1988 Nov; 41(11):1623-34. PubMed ID: 3145344
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.
Critchley IA; Sahm DF; Kelly LJ; Karlowsky JA
Chemotherapy; 2003 May; 49(1-2):44-8. PubMed ID: 12714810
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
Kurtz TO; Winston DJ; Bruckner DA; Martin WJ
Antimicrob Agents Chemother; 1981 Aug; 20(2):239-43. PubMed ID: 6792982
[TBL] [Abstract][Full Text] [Related]
14. In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.
Araoka H; Baba M; Tateda K; Ishii Y; Oguri T; Okuzumi K; Oishi T; Mori S; Mitsuda T; Moriya K; Nakamori Y; Ohmagari N; Yamaguchi K; Yoneyama A;
Jpn J Infect Dis; 2012; 65(1):84-7. PubMed ID: 22274165
[TBL] [Abstract][Full Text] [Related]
15. [Studies on aztreonam in the perinatal period].
Cho N; Fukunaga K; Kunii K; Kobayashi I
Jpn J Antibiot; 1990 Apr; 43(4):706-18. PubMed ID: 2116538
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pharmacokinetic studies on aztreonam in neonates].
Hashira S; Tajima T; Meguro H; Abe T; Fujii R
Jpn J Antibiot; 1990 Mar; 43(3):396-404. PubMed ID: 2374292
[TBL] [Abstract][Full Text] [Related]
17. [Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
Shiritani Y; Yamaji S; Aoki A; Saigusa M; Yokoiyama S; Gato S; Tsuji A
Jpn J Antibiot; 1988 Nov; 41(11):1591-9. PubMed ID: 3145343
[TBL] [Abstract][Full Text] [Related]
18. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Baltch AL; Bassey C; Fanciullo G; Smith RP
J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
[TBL] [Abstract][Full Text] [Related]
19. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
[TBL] [Abstract][Full Text] [Related]
20. [The combined effects of aspoxicillin with aminoglycoside antibiotics on Pseudomonas aeruginosa].
Matsushita T; Kasuga O; Yamaguchi T
Jpn J Antibiot; 1990 Apr; 43(4):677-85. PubMed ID: 2116537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
